Suzuken Co Ltd - Company Profile
Powered by 
All the data and insights you need on Suzuken Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Suzuken Co Ltd Strategy Report
- Understand Suzuken Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Suzuken Co Ltd (Suzuken) is a distributor of pharmaceuticals, medical equipment and supplies, diagnostic reagents, and medical foods. It develops and manufactures sphygmomanometers, electrocardiographs (ECGs), other medical equipment, and diagnostic products and pharmaceuticals for diabetes and kidney diseases. The company conducts research to advance its pipeline products for the treatment of constipation, renal anemia, hyperparathyroidism, pruritus, nocturia and type 2 diabetes, chronic kidney disease. It also provides nursing care; manufacturer support services including contract distribution services and distribution of orphan drugs; food and nursing services; and training and education for local insurance pharmacies. It serves hospitals, clinics, insurance pharmacies, pharmaceutical companies, and medical institutions in Japan. Suzuken is headquartered in Nagoya, Aichi Prefecture, Japan.
Headquarters
Japan
Address
8, Higashi Kataha-Machi, Higashi-Ku, Nagoya-Shi, Aichi, 461-8701
Website
www.suzuken.co.jp
Telephone
81 52 9612331
No of Employees
13,429
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
9987 (TYO)
Revenue (2022)
$17.1B
3.4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
41.3%
(2022 vs 2021)
Market Cap*
$2.3B
Net Profit Margin (2022)
XYZ
37.5%
(2022 vs 2021)
* As of and is in US$
Suzuken Co Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Pharmaceuticals | Pharmaceutical Distribution Services |
| Diagnostic Products | Contract Distribution Services |
| Sphygmomanometers | Distribution of Orphan Drugs |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Plans/Strategy | In March, the company announced its plans to begin operations at the Greater Tokyo Distribution Center in Soka, Saitama Prefecture, Japan. |
| 2023 | Plans/Strategy | In November, the company announced its plans to acquire a 16.61% stake in Welby from Digital Garage. |
| 2023 | Plans/Strategy | In November, the company announced its plans to acquire a minority stake in Pharmarise Holdings. |
Competitor Comparison
| Key Parameters | Suzuken Co Ltd | Sumitomo Chemical Co Ltd | Alfresa Holdings Corp | Astellas Pharma Inc | Kyowa Kirin Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Nagoya-Shi | Chuo-Ku | Chiyoda-Ku | Chuo-Ku | Chiyoda-Ku |
| State/Province | Aichi | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 13,429 | 33,572 | 11,772 | 14,484 | 5,974 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hiromi Miyata | Executive Officer; Chairman | Executive Board | 2022 | - |
| Shigeru Asano | Chief Executive Officer; President | Senior Management | 2022 | - |
| Yoshiki Bessho | Director; Executive Officer | Executive Board | 2021 | - |
| Chie Takahashi | Director; Executive Officer; General Manager of Pharmaceutical Affairs Supervisory Office | Executive Board | 2020 | - |
| Asako Tomita | Executive Officer | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward